HEADER HYDROLASE 04-FEB-11 2Y8C TITLE PLASMODIUM FALCIPARUM DUTPASE IN COMPLEX WITH A TRITYL LIGAND CAVEAT 2Y8C DUQ C 400 HAS WRONG CHIRALITY AT ATOM C1 DUQ A 400 HAS WRONG CAVEAT 2 2Y8C CHIRALITY AT ATOM C1 DUQ B 400 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 2Y8C C1 THR A 21 C-ALPHA IS PLANAR MET B 1 C-ALPHA IS PLANAR COMPND MOL_ID: 1; COMPND 2 MOLECULE: DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDE-HYDROLASE; COMPND 5 EC: 3.6.1.23; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: ONE TRITYL ANALOGUE ASSOCIATED WITH EACH PROTEIN CHAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: 3D7; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET11 KEYWDS HYDROLASE, MALARIA EXPDTA X-RAY DIFFRACTION AUTHOR B.BARAGANA,O.MCCARTHY,P.SANCHEZ,C.BOSCH,M.KAISER,R.BRUN, AUTHOR 2 J.L.WHITTINGHAM,S.ROBERTS,X.-X.ZHOU,K.S.WILSON,N.G.JOHANSSON, AUTHOR 3 D.GONZALEZ-PACANOWSKA,I.H.GILBERT REVDAT 2 20-DEC-23 2Y8C 1 REMARK REVDAT 1 07-MAR-12 2Y8C 0 JRNL AUTH B.BARAGANA,O.MCCARTHY,P.SANCHEZ,C.BOSCH,M.KAISER,R.BRUN, JRNL AUTH 2 J.L.WHITTINGHAM,S.ROBERTS,X.-X.ZHOU,K.S.WILSON, JRNL AUTH 3 N.G.JOHANSSON,D.GONZALEZ-PACANOWSKA,I.H.GILBERT JRNL TITL BETA-BRANCHED ACYCLIC NUCLEOSIDE ANALOGUES AS INHIBITORS OF JRNL TITL 2 PLASMODIUM FALCIPARUM DUTPASE JRNL REF BIOORG.MED.CHEM. V. 19 2378 2011 JRNL REFN ISSN 0968-0896 JRNL PMID 21411327 JRNL DOI 10.1016/J.BMC.2011.02.012 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0119 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 35984 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1902 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2620 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE SET COUNT : 127 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3154 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 121 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : -0.02000 REMARK 3 B33 (A**2) : 0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.151 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.154 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.103 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.801 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3166 ; 0.020 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4271 ; 2.258 ; 2.025 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 387 ; 7.916 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 119 ;31.814 ;24.538 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 523 ;17.118 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;22.020 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 497 ; 0.222 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2312 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT. U VALUES REFINED INDIVIDUALLY. REMARK 4 REMARK 4 2Y8C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1290046838. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-DEC-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35984 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 38.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1VYQ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 3.3M AMMONIUM SULPHATE, 0.1M BIS-TRIS REMARK 280 PH 6.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.49000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 27.74500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 83.23500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 58 REMARK 465 LYS A 59 REMARK 465 SER A 60 REMARK 465 ASN A 61 REMARK 465 TYR A 62 REMARK 465 TYR A 63 REMARK 465 TYR A 64 REMARK 465 LYS A 65 REMARK 465 CYS A 66 REMARK 465 GLU A 67 REMARK 465 LYS A 68 REMARK 465 SER A 69 REMARK 465 GLU A 70 REMARK 465 ASN A 71 REMARK 465 LYS A 72 REMARK 465 LYS A 73 REMARK 465 LYS A 74 REMARK 465 ASP A 75 REMARK 465 ASP A 76 REMARK 465 ASP A 77 REMARK 465 LYS A 78 REMARK 465 SER A 79 REMARK 465 THR A 168 REMARK 465 SER A 169 REMARK 465 ASN A 170 REMARK 465 ASN A 171 REMARK 465 LYS A 172 REMARK 465 TYR A 173 REMARK 465 LYS B 20 REMARK 465 THR B 21 REMARK 465 HIS B 22 REMARK 465 HIS B 23 REMARK 465 GLU B 24 REMARK 465 GLY B 25 REMARK 465 TYR B 58 REMARK 465 LYS B 59 REMARK 465 SER B 60 REMARK 465 ASN B 61 REMARK 465 TYR B 62 REMARK 465 TYR B 63 REMARK 465 TYR B 64 REMARK 465 LYS B 65 REMARK 465 CYS B 66 REMARK 465 GLU B 67 REMARK 465 LYS B 68 REMARK 465 SER B 69 REMARK 465 GLU B 70 REMARK 465 ASN B 71 REMARK 465 LYS B 72 REMARK 465 LYS B 73 REMARK 465 LYS B 74 REMARK 465 ASP B 75 REMARK 465 ASP B 76 REMARK 465 ASP B 77 REMARK 465 LYS B 78 REMARK 465 SER B 79 REMARK 465 ASN B 80 REMARK 465 ILE B 81 REMARK 465 VAL B 82 REMARK 465 LEU B 155 REMARK 465 ASP B 156 REMARK 465 GLU B 157 REMARK 465 THR B 158 REMARK 465 SER B 159 REMARK 465 ARG B 160 REMARK 465 GLY B 161 REMARK 465 GLU B 162 REMARK 465 GLY B 163 REMARK 465 GLY B 164 REMARK 465 PHE B 165 REMARK 465 GLY B 166 REMARK 465 SER B 167 REMARK 465 THR B 168 REMARK 465 SER B 169 REMARK 465 ASN B 170 REMARK 465 ASN B 171 REMARK 465 LYS B 172 REMARK 465 TYR B 173 REMARK 465 LYS C 20 REMARK 465 THR C 21 REMARK 465 HIS C 22 REMARK 465 HIS C 23 REMARK 465 GLU C 24 REMARK 465 GLY C 25 REMARK 465 ASP C 26 REMARK 465 TYR C 58 REMARK 465 LYS C 59 REMARK 465 SER C 60 REMARK 465 ASN C 61 REMARK 465 TYR C 62 REMARK 465 TYR C 63 REMARK 465 TYR C 64 REMARK 465 LYS C 65 REMARK 465 CYS C 66 REMARK 465 GLU C 67 REMARK 465 LYS C 68 REMARK 465 SER C 69 REMARK 465 GLU C 70 REMARK 465 ASN C 71 REMARK 465 LYS C 72 REMARK 465 LYS C 73 REMARK 465 LYS C 74 REMARK 465 ASP C 75 REMARK 465 ASP C 76 REMARK 465 ASP C 77 REMARK 465 LYS C 78 REMARK 465 SER C 79 REMARK 465 ASN C 80 REMARK 465 ILE C 81 REMARK 465 THR C 168 REMARK 465 SER C 169 REMARK 465 ASN C 170 REMARK 465 ASN C 171 REMARK 465 LYS C 172 REMARK 465 TYR C 173 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 167 CB OG REMARK 470 LYS B 4 CB CG CD CE NZ REMARK 470 GLU B 14 CB CG CD OE1 OE2 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 LYS A 20 REMARK 475 GLU A 24 REMARK 475 GLY A 25 REMARK 475 ASP B 26 REMARK 475 GLU B 153 REMARK 475 GLU B 154 REMARK 475 SER C 167 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 4 CE NZ REMARK 480 LYS A 17 CD CE NZ REMARK 480 ASN A 18 CB CG OD1 ND2 REMARK 480 THR A 21 N CB OG1 CG2 REMARK 480 ASP A 26 CB CG OD1 OD2 REMARK 480 LYS A 35 CD CE NZ REMARK 480 LYS A 40 CD CE NZ REMARK 480 LYS A 48 CE NZ REMARK 480 GLN A 57 CG CD OE1 NE2 REMARK 480 ASN A 80 CG OD1 ND2 REMARK 480 ILE A 81 CD1 REMARK 480 GLN A 126 CG CD OE1 NE2 REMARK 480 LYS A 131 CG CD CE NZ REMARK 480 GLU A 145 CG CD OE1 OE2 REMARK 480 MET B 1 CB CG SD CE REMARK 480 ILE B 5 CD1 REMARK 480 ARG B 13 CB CG CD NE CZ NH1 NH2 REMARK 480 LYS B 17 CG CD CE NZ REMARK 480 HIS B 19 C O REMARK 480 LYS B 35 CG CD CE NZ REMARK 480 LYS B 48 CE NZ REMARK 480 ILE B 54 CD1 REMARK 480 GLN B 57 CB CG CD OE1 NE2 REMARK 480 LYS B 96 CD CE NZ REMARK 480 GLU B 127 CD OE1 OE2 REMARK 480 LYS B 131 CD CE NZ REMARK 480 LYS B 132 CG CD CE NZ REMARK 480 LYS C 4 CE NZ REMARK 480 LYS C 17 CG CD CE NZ REMARK 480 ASN C 18 CB CG OD1 ND2 REMARK 480 GLN C 57 O REMARK 480 LYS C 131 CD CE NZ REMARK 480 GLU C 145 CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HIS A 19 N LYS A 20 0.30 REMARK 500 O HIS A 19 CA LYS A 20 1.27 REMARK 500 O VAL B 152 N GLU B 153 1.31 REMARK 500 OE1 GLU B 11 NZ LYS B 132 1.45 REMARK 500 C LYS A 20 CA THR A 21 1.64 REMARK 500 O GLY A 25 N ASP A 26 1.70 REMARK 500 CD1 ILE B 54 NH1 ARG B 113 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 19 C LYS A 20 N -0.339 REMARK 500 THR A 21 N THR A 21 CA -0.876 REMARK 500 THR A 21 CA THR A 21 CB 0.391 REMARK 500 GLY A 25 C ASP A 26 N -0.485 REMARK 500 ASP A 26 CA ASP A 26 CB -0.217 REMARK 500 LYS A 40 CG LYS A 40 CD -0.276 REMARK 500 GLN A 57 CB GLN A 57 CG -0.264 REMARK 500 ASN A 80 CB ASN A 80 CG -0.622 REMARK 500 LYS A 131 CB LYS A 131 CG -0.225 REMARK 500 GLU A 145 CB GLU A 145 CG 0.465 REMARK 500 MET B 1 CA MET B 1 CB -0.297 REMARK 500 ARG B 13 CA ARG B 13 CB -0.284 REMARK 500 HIS B 19 CA HIS B 19 C -0.652 REMARK 500 ASP B 26 C SER B 27 N -0.175 REMARK 500 GLN B 57 CA GLN B 57 CB -0.397 REMARK 500 LYS B 96 CG LYS B 96 CD 0.458 REMARK 500 GLU B 127 CG GLU B 127 CD -0.361 REMARK 500 HIS B 129 CG HIS B 129 CD2 0.054 REMARK 500 LYS B 131 CG LYS B 131 CD -0.281 REMARK 500 VAL B 152 C GLU B 153 N -0.425 REMARK 500 LYS C 17 CB LYS C 17 CG -0.439 REMARK 500 GLN C 57 C GLN C 57 O -0.478 REMARK 500 GLU C 145 CA GLU C 145 CB -0.166 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 HIS A 19 O - C - N ANGL. DEV. = 115.1 DEGREES REMARK 500 LYS A 20 C - N - CA ANGL. DEV. = 26.1 DEGREES REMARK 500 THR A 21 CB - CA - C ANGL. DEV. = -32.9 DEGREES REMARK 500 THR A 21 N - CA - CB ANGL. DEV. = 50.4 DEGREES REMARK 500 THR A 21 CA - CB - OG1 ANGL. DEV. = -14.5 DEGREES REMARK 500 THR A 21 CA - CB - CG2 ANGL. DEV. = -20.0 DEGREES REMARK 500 GLY A 25 O - C - N ANGL. DEV. = -13.6 DEGREES REMARK 500 ASP A 26 C - N - CA ANGL. DEV. = 16.4 DEGREES REMARK 500 ASN A 80 CB - CG - OD1 ANGL. DEV. = -18.2 DEGREES REMARK 500 ASN A 80 CB - CG - ND2 ANGL. DEV. = 17.0 DEGREES REMARK 500 ILE A 116 CG1 - CB - CG2 ANGL. DEV. = -19.0 DEGREES REMARK 500 LYS A 131 CA - CB - CG ANGL. DEV. = 14.8 DEGREES REMARK 500 GLU A 145 CA - CB - CG ANGL. DEV. = -16.1 DEGREES REMARK 500 MET B 1 N - CA - CB ANGL. DEV. = 20.8 DEGREES REMARK 500 ARG B 13 N - CA - CB ANGL. DEV. = 17.4 DEGREES REMARK 500 GLN B 57 CB - CA - C ANGL. DEV. = -14.6 DEGREES REMARK 500 GLN B 57 N - CA - CB ANGL. DEV. = 13.8 DEGREES REMARK 500 LYS B 96 CB - CG - CD ANGL. DEV. = -32.6 DEGREES REMARK 500 LYS B 131 CB - CG - CD ANGL. DEV. = 24.7 DEGREES REMARK 500 VAL B 152 CA - C - N ANGL. DEV. = 47.4 DEGREES REMARK 500 VAL B 152 O - C - N ANGL. DEV. = -49.0 DEGREES REMARK 500 GLU B 153 C - N - CA ANGL. DEV. = 37.3 DEGREES REMARK 500 LYS C 17 CA - CB - CG ANGL. DEV. = 14.9 DEGREES REMARK 500 ASN C 18 CB - CA - C ANGL. DEV. = -17.0 DEGREES REMARK 500 ASP C 30 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 VAL C 137 CG1 - CB - CG2 ANGL. DEV. = 14.9 DEGREES REMARK 500 GLU C 145 N - CA - CB ANGL. DEV. = 11.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 18 41.81 -97.60 REMARK 500 LYS A 20 -23.76 -144.44 REMARK 500 ASP A 26 114.44 57.72 REMARK 500 SER A 104 -76.92 76.50 REMARK 500 ASN A 133 -11.16 81.45 REMARK 500 ASP A 156 -168.85 -163.36 REMARK 500 GLU B 37 143.69 -170.00 REMARK 500 SER B 104 -70.50 69.84 REMARK 500 ASN B 133 -16.07 83.02 REMARK 500 ASN C 18 48.93 -98.66 REMARK 500 SER C 104 -66.43 64.37 REMARK 500 ASN C 133 -16.28 77.48 REMARK 500 ASP C 156 -163.82 -166.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 HIS A 19 LYS A 20 -132.24 REMARK 500 LYS A 20 THR A 21 -145.05 REMARK 500 GLY C 111 TYR C 112 -135.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 HIS A 19 151.43 REMARK 500 VAL B 152 -15.29 REMARK 500 GLY C 166 13.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DUQ A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1168 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DUQ B 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DUQ C 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 1168 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1VYQ RELATED DB: PDB REMARK 900 NOVEL INHIBITORS OF PLASMODIUM FALCIPARUM DUTPASE PROVIDE A REMARK 900 PLATFORM FOR ANTI-MALARIAL DRUG DESIGN DBREF 2Y8C A 1 173 UNP Q8II92 Q8II92_PLAF7 1 173 DBREF 2Y8C B 1 173 UNP Q8II92 Q8II92_PLAF7 1 173 DBREF 2Y8C C 1 173 UNP Q8II92 Q8II92_PLAF7 1 173 SEQRES 1 A 173 MET HIS LEU LYS ILE VAL CYS LEU SER ASP GLU VAL ARG SEQRES 2 A 173 GLU MET TYR LYS ASN HIS LYS THR HIS HIS GLU GLY ASP SEQRES 3 A 173 SER GLY LEU ASP LEU PHE ILE VAL LYS ASP GLU VAL LEU SEQRES 4 A 173 LYS PRO LYS SER THR THR PHE VAL LYS LEU GLY ILE LYS SEQRES 5 A 173 ALA ILE ALA LEU GLN TYR LYS SER ASN TYR TYR TYR LYS SEQRES 6 A 173 CYS GLU LYS SER GLU ASN LYS LYS LYS ASP ASP ASP LYS SEQRES 7 A 173 SER ASN ILE VAL ASN THR SER PHE LEU LEU PHE PRO ARG SEQRES 8 A 173 SER SER ILE SER LYS THR PRO LEU ARG LEU ALA ASN SER SEQRES 9 A 173 ILE GLY LEU ILE ASP ALA GLY TYR ARG GLY GLU ILE ILE SEQRES 10 A 173 ALA ALA LEU ASP ASN THR SER ASP GLN GLU TYR HIS ILE SEQRES 11 A 173 LYS LYS ASN ASP LYS LEU VAL GLN LEU VAL SER PHE THR SEQRES 12 A 173 GLY GLU PRO LEU SER PHE GLU LEU VAL GLU GLU LEU ASP SEQRES 13 A 173 GLU THR SER ARG GLY GLU GLY GLY PHE GLY SER THR SER SEQRES 14 A 173 ASN ASN LYS TYR SEQRES 1 B 173 MET HIS LEU LYS ILE VAL CYS LEU SER ASP GLU VAL ARG SEQRES 2 B 173 GLU MET TYR LYS ASN HIS LYS THR HIS HIS GLU GLY ASP SEQRES 3 B 173 SER GLY LEU ASP LEU PHE ILE VAL LYS ASP GLU VAL LEU SEQRES 4 B 173 LYS PRO LYS SER THR THR PHE VAL LYS LEU GLY ILE LYS SEQRES 5 B 173 ALA ILE ALA LEU GLN TYR LYS SER ASN TYR TYR TYR LYS SEQRES 6 B 173 CYS GLU LYS SER GLU ASN LYS LYS LYS ASP ASP ASP LYS SEQRES 7 B 173 SER ASN ILE VAL ASN THR SER PHE LEU LEU PHE PRO ARG SEQRES 8 B 173 SER SER ILE SER LYS THR PRO LEU ARG LEU ALA ASN SER SEQRES 9 B 173 ILE GLY LEU ILE ASP ALA GLY TYR ARG GLY GLU ILE ILE SEQRES 10 B 173 ALA ALA LEU ASP ASN THR SER ASP GLN GLU TYR HIS ILE SEQRES 11 B 173 LYS LYS ASN ASP LYS LEU VAL GLN LEU VAL SER PHE THR SEQRES 12 B 173 GLY GLU PRO LEU SER PHE GLU LEU VAL GLU GLU LEU ASP SEQRES 13 B 173 GLU THR SER ARG GLY GLU GLY GLY PHE GLY SER THR SER SEQRES 14 B 173 ASN ASN LYS TYR SEQRES 1 C 173 MET HIS LEU LYS ILE VAL CYS LEU SER ASP GLU VAL ARG SEQRES 2 C 173 GLU MET TYR LYS ASN HIS LYS THR HIS HIS GLU GLY ASP SEQRES 3 C 173 SER GLY LEU ASP LEU PHE ILE VAL LYS ASP GLU VAL LEU SEQRES 4 C 173 LYS PRO LYS SER THR THR PHE VAL LYS LEU GLY ILE LYS SEQRES 5 C 173 ALA ILE ALA LEU GLN TYR LYS SER ASN TYR TYR TYR LYS SEQRES 6 C 173 CYS GLU LYS SER GLU ASN LYS LYS LYS ASP ASP ASP LYS SEQRES 7 C 173 SER ASN ILE VAL ASN THR SER PHE LEU LEU PHE PRO ARG SEQRES 8 C 173 SER SER ILE SER LYS THR PRO LEU ARG LEU ALA ASN SER SEQRES 9 C 173 ILE GLY LEU ILE ASP ALA GLY TYR ARG GLY GLU ILE ILE SEQRES 10 C 173 ALA ALA LEU ASP ASN THR SER ASP GLN GLU TYR HIS ILE SEQRES 11 C 173 LYS LYS ASN ASP LYS LEU VAL GLN LEU VAL SER PHE THR SEQRES 12 C 173 GLY GLU PRO LEU SER PHE GLU LEU VAL GLU GLU LEU ASP SEQRES 13 C 173 GLU THR SER ARG GLY GLU GLY GLY PHE GLY SER THR SER SEQRES 14 C 173 ASN ASN LYS TYR HET DUQ A 400 38 HET SO4 A1168 5 HET DUQ B 400 38 HET DUQ C 400 38 HET SO4 C1168 5 HETNAM DUQ (2S)-2-[(2,4-DIOXOPYRIMIDIN-1-YL)METHYL]-N-(2- HETNAM 2 DUQ HYDROXYETHYL)-4-TRITYLOXY-BUTANAMIDE HETNAM SO4 SULFATE ION HETSYN DUQ 5'-TRITYLATED DEOXYURIDINE ANALOGUE FORMUL 4 DUQ 3(C30 H31 N3 O5) FORMUL 5 SO4 2(O4 S 2-) FORMUL 9 HOH *121(H2 O) HELIX 1 1 SER A 9 ASN A 18 1 10 HELIX 2 2 SER A 92 THR A 97 5 6 HELIX 3 3 SER B 9 ASN B 18 1 10 HELIX 4 4 SER B 92 THR B 97 5 6 HELIX 5 5 SER C 9 ASN C 18 1 10 HELIX 6 6 SER C 92 THR C 97 5 6 SHEET 1 AA 4 VAL A 82 THR A 84 0 SHEET 2 AA 4 ILE A 51 GLN A 57 -1 O ALA A 55 N THR A 84 SHEET 3 AA 4 HIS A 2 CYS A 7 -1 O HIS A 2 N LEU A 56 SHEET 4 AA 4 SER A 148 LEU A 151 1 O SER A 148 N LEU A 3 SHEET 1 AB 4 GLY A 28 PHE A 32 0 SHEET 2 AB 4 LYS A 135 VAL A 140 -1 N LEU A 136 O LEU A 31 SHEET 3 AB 4 PHE A 86 PRO A 90 -1 O LEU A 87 N VAL A 140 SHEET 4 AB 4 GLY A 106 ILE A 108 -1 O GLY A 106 N LEU A 88 SHEET 1 AC 2 GLU A 37 LEU A 39 0 SHEET 2 AC 2 TYR A 128 ILE A 130 -1 O TYR A 128 N LEU A 39 SHEET 1 AD 3 SER A 43 LYS A 48 0 SHEET 2 AD 3 ILE A 117 ASN A 122 -1 O ALA A 118 N VAL A 47 SHEET 3 AD 3 LEU A 99 LEU A 101 -1 O ARG A 100 N ASP A 121 SHEET 1 BA 3 ILE B 51 LEU B 56 0 SHEET 2 BA 3 HIS B 2 CYS B 7 -1 O HIS B 2 N LEU B 56 SHEET 3 BA 3 SER B 148 LEU B 151 1 O SER B 148 N LEU B 3 SHEET 1 BB 4 GLY B 28 PHE B 32 0 SHEET 2 BB 4 LYS B 135 VAL B 140 -1 O VAL B 137 N LEU B 31 SHEET 3 BB 4 PHE B 86 PRO B 90 -1 O LEU B 87 N VAL B 140 SHEET 4 BB 4 GLY B 106 ILE B 108 -1 O GLY B 106 N LEU B 88 SHEET 1 BC 2 GLU B 37 LEU B 39 0 SHEET 2 BC 2 TYR B 128 ILE B 130 -1 O TYR B 128 N LEU B 39 SHEET 1 BD 3 SER B 43 LYS B 48 0 SHEET 2 BD 3 ILE B 117 ASN B 122 -1 O ALA B 118 N VAL B 47 SHEET 3 BD 3 LEU B 99 LEU B 101 -1 O ARG B 100 N ASP B 121 SHEET 1 CA 4 ASN C 83 THR C 84 0 SHEET 2 CA 4 ILE C 51 LEU C 56 -1 O ALA C 55 N THR C 84 SHEET 3 CA 4 HIS C 2 CYS C 7 -1 O HIS C 2 N LEU C 56 SHEET 4 CA 4 SER C 148 LEU C 151 1 O SER C 148 N LEU C 3 SHEET 1 CB 4 GLY C 28 PHE C 32 0 SHEET 2 CB 4 LYS C 135 VAL C 140 -1 N LEU C 136 O LEU C 31 SHEET 3 CB 4 PHE C 86 PRO C 90 -1 O LEU C 87 N VAL C 140 SHEET 4 CB 4 GLY C 106 ILE C 108 -1 O GLY C 106 N LEU C 88 SHEET 1 CC 2 GLU C 37 LEU C 39 0 SHEET 2 CC 2 TYR C 128 ILE C 130 -1 O TYR C 128 N LEU C 39 SHEET 1 CD 3 SER C 43 LYS C 48 0 SHEET 2 CD 3 ILE C 117 ASN C 122 -1 O ALA C 118 N VAL C 47 SHEET 3 CD 3 LEU C 99 LEU C 101 -1 O ARG C 100 N ASP C 121 SITE 1 AC1 11 PHE A 46 LEU A 88 ASN A 103 GLY A 106 SITE 2 AC1 11 LEU A 107 TYR A 112 ILE A 117 ALA A 119 SITE 3 AC1 11 ARG A 160 HOH A2040 SER B 92 SITE 1 AC2 4 ARG A 91 SER A 92 GLN A 138 HOH A2033 SITE 1 AC3 9 PHE B 46 LEU B 88 ASN B 103 GLY B 106 SITE 2 AC3 9 LEU B 107 TYR B 112 ILE B 117 HOH B2012 SITE 3 AC3 9 SER C 92 SITE 1 AC4 10 SER A 92 PHE C 46 LEU C 88 ASN C 103 SITE 2 AC4 10 GLY C 106 LEU C 107 TYR C 112 ILE C 117 SITE 3 AC4 10 ALA C 119 HOH C2027 SITE 1 AC5 5 GLY C 111 TYR C 112 ARG C 113 GLY C 114 SITE 2 AC5 5 ARG C 160 CRYST1 77.160 77.160 110.980 90.00 90.00 90.00 P 41 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012960 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012960 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009011 0.00000